Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jieyu Capsule is a Traditional Chinese Medicine (TCM) developed by Sanjiu Medical & Pharmaceutical (999 Pharmaceutical) for the treatment of mild to moderate depression. It is a standardized herbal combination product primarily composed of extracts from *Hypericum perforatum* (St. John's Wort) and *Eleutherococcus senticosus* (Siberian Ginseng). The therapeutic efficacy is largely attributed to the *Hypericum* component, which contains active compounds such as hyperforin and hypericin; these compounds act as non-selective inhibitors of the reuptake of monoamine neurotransmitters, including serotonin (5-HT), norepinephrine (NE), and dopamine (DA). The *Eleutherococcus* component serves as an adaptogen, enhancing mental and physical resilience and helping to alleviate symptoms of fatigue and stress. Jieyu Capsule is approved in China and is frequently used as a natural alternative to synthetic antidepressants due to its efficacy and relatively low incidence of side effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jieyu Capsule.